236 related articles for article (PubMed ID: 30125616)
1. Neuraminidase inhibitors susceptibility profiles of highly pathogenic influenza A (H5N1) viruses isolated from avian species in India (2006-2015).
Sood R; Kumar N; Bhatia S; Chanu KV; Gupta CL; Pateriya AK; Mishra A; Khandia R; Mawale N; Singh VP
Antiviral Res; 2018 Oct; 158():143-146. PubMed ID: 30125616
[TBL] [Abstract][Full Text] [Related]
2. A novel I117T substitution in neuraminidase of highly pathogenic avian influenza H5N1 virus conferring reduced susceptibility to oseltamivir and zanamivir.
Kode SS; Pawar SD; Tare DS; Keng SS; Hurt AC; Mullick J
Vet Microbiol; 2019 Aug; 235():21-24. PubMed ID: 31282375
[TBL] [Abstract][Full Text] [Related]
3. Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors.
Baek YH; Song MS; Lee EY; Kim YI; Kim EH; Park SJ; Park KJ; Kwon HI; Pascua PN; Lim GJ; Kim S; Yoon SW; Kim MH; Webby RJ; Choi YK
J Virol; 2015 Jan; 89(1):287-99. PubMed ID: 25320319
[TBL] [Abstract][Full Text] [Related]
4. Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6, and N8 Neuraminidase Subtypes.
Choi WS; Jeong JH; Kwon JJ; Ahn SJ; Lloren KKS; Kwon HI; Chae HB; Hwang J; Kim MH; Kim CJ; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046464
[TBL] [Abstract][Full Text] [Related]
5. Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets.
Ilyushina NA; Seiler JP; Rehg JE; Webster RG; Govorkova EA
PLoS Pathog; 2010 May; 6(5):e1000933. PubMed ID: 20523902
[TBL] [Abstract][Full Text] [Related]
6. Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring.
Govorkova EA; Baranovich T; Seiler P; Armstrong J; Burnham A; Guan Y; Peiris M; Webby RJ; Webster RG
Antiviral Res; 2013 May; 98(2):297-304. PubMed ID: 23458714
[TBL] [Abstract][Full Text] [Related]
7. Identification of Indonesian clade 2.1 highly pathogenic influenza A(H5N1) viruses with N294S and S246N neuraminidase substitutions which further reduce oseltamivir susceptibility.
McKimm-Breschkin JL; Barrett S; Wong FYK; Pudjiatmoko ; Azhar M; Selleck P; Davies KR; Hartaningsih N; McGrane J
Antiviral Res; 2018 May; 153():95-100. PubMed ID: 29574145
[TBL] [Abstract][Full Text] [Related]
8. Highly pathogenic avian influenza H7N9 viruses with reduced susceptibility to neuraminidase inhibitors showed comparable replication capacity to their sensitive counterparts.
Tang J; Zhang J; Zhou J; Zhu W; Yang L; Zou S; Wei H; Xin L; Huang W; Li X; Cheng Y; Wang D
Virol J; 2019 Jul; 16(1):87. PubMed ID: 31266524
[TBL] [Abstract][Full Text] [Related]
9. Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.
Burnham AJ; Armstrong J; Lowen AC; Webster RG; Govorkova EA
J Virol; 2015 Apr; 89(8):4575-87. PubMed ID: 25673705
[TBL] [Abstract][Full Text] [Related]
10. Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza viruses.
Ilyushina NA; Govorkova EA; Gray TE; Bovin NV; Webster RG
PLoS Pathog; 2008 Apr; 4(4):e1000043. PubMed ID: 18404209
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses.
Takano R; Kiso M; Igarashi M; Le QM; Sekijima M; Ito K; Takada A; Kawaoka Y
J Infect Dis; 2013 Jan; 207(1):89-97. PubMed ID: 23053629
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.
Hurt AC; Selleck P; Komadina N; Shaw R; Brown L; Barr IG
Antiviral Res; 2007 Mar; 73(3):228-31. PubMed ID: 17112602
[TBL] [Abstract][Full Text] [Related]
13. Assessing the susceptibility of highly pathogenic avian influenza H5N1 viruses to oseltamivir using embryonated chicken eggs.
Tare DS; Kode SS; Hurt AC; Pawar SD
Indian J Med Res; 2019 Nov; 150(5):486-491. PubMed ID: 31939392
[TBL] [Abstract][Full Text] [Related]
14. Effect of influenza H1N1 neuraminidase V116A and I117V mutations on NA activity and sensitivity to NA inhibitors.
Adams SE; Lee N; Lugovtsev VY; Kan A; Donnelly RP; Ilyushina NA
Antiviral Res; 2019 Sep; 169():104539. PubMed ID: 31228489
[TBL] [Abstract][Full Text] [Related]
15. Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses isolated from birds and mammals in the United States, 2022.
Nguyen HT; Chesnokov A; De La Cruz J; Pascua PNQ; Mishin VP; Jang Y; Jones J; Di H; Ivashchenko AA; Killian ML; Torchetti MK; Lantz K; Wentworth DE; Davis CT; Ivachtchenko AV; Gubareva LV
Antiviral Res; 2023 Sep; 217():105679. PubMed ID: 37494978
[TBL] [Abstract][Full Text] [Related]
16. I222 Neuraminidase mutations further reduce oseltamivir susceptibility of Indonesian Clade 2.1 highly pathogenic Avian Influenza A(H5N1) viruses.
McKimm-Breschkin JL; Barrett S; Pudjiatmoko ; Azhar M; Wong FY; Selleck P; Mohr PG; McGrane J; Kim M
PLoS One; 2013; 8(6):e66105. PubMed ID: 23776615
[TBL] [Abstract][Full Text] [Related]
17. Profile and generation of reduced neuraminidase inhibitor susceptibility in highly pathogenic avian influenza H7N9 virus from human cases in Mainland of China, 2016-2019.
Tang J; Zhang SX; Zhang J; Li XY; Zhou JF; Zou SM; Bo H; Xin L; Yang L; Liu J; Huang WJ; Dong J; Wang DY
Virology; 2020 Oct; 549():77-84. PubMed ID: 32853849
[TBL] [Abstract][Full Text] [Related]
18. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.
Yen HL; Ilyushina NA; Salomon R; Hoffmann E; Webster RG; Govorkova EA
J Virol; 2007 Nov; 81(22):12418-26. PubMed ID: 17855542
[TBL] [Abstract][Full Text] [Related]
19. Functional neuraminidase inhibitor resistance motifs in avian influenza A(H5Nx) viruses.
Bialy D; Shelton H
Antiviral Res; 2020 Oct; 182():104886. PubMed ID: 32750468
[TBL] [Abstract][Full Text] [Related]
20. Characterization of substitutions in the neuraminidase of A(H7N9) influenza viruses selected following serial passage in the presence of different neuraminidase inhibitors.
Farrukee R; Butler J; Reading PC; Hurt AC
Antiviral Res; 2019 Aug; 168():68-75. PubMed ID: 31132385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
